Kenvue Inc.
KVUE
Rank in Stocks
#663
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Share Price
$19.29
Last synced: 2026-10-20
Market Cap
$37.05B
Change (1 day)
2.23%
Change (1 year)
29.20%
Country
US
Trade Kenvue Inc. (KVUE)
Category
Consumer Defensive
Revenue for Kenvue Inc. (KVUE)
Revenue in Jun 2026 TTM: $15.41B
According to Kenvue Inc. latest financial reports the company's current revenue (TTM) is $15.41B. In 2023 the company made a revenue of $15.44B an increase over the revenue in the year 2022 that was $14.95B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Kenvue Inc. from 2019 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $15.41B | -0.30% |
| 2024 | $15.46B | 0.07% |
| 2023 | $15.44B | 3.30% |
| 2022 | $14.95B | -0.69% |
| 2021 | $15.05B | 4.06% |
| 2020 | $14.47B | 1.00% |
| 2019 | $14.32B | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $87.03B | 464.85% |
US
|
|
| $51.67B | 235.32% |
FR
|
|
| $21.05B | 36.59% |
US
|
|
| $7.28B | -52.72% |
IN
|
|
| $15.05B | -2.33% |
US
|
